1ZTS:BIT
Zoetis Inc
61,60 €
arrow_downward
-0,93%(-0,58) 1D
2 paź, 17:26:00 GMT+2 · EUR
search
Wszystkie symbole
| Symbol | Cena | Zmiana | Zmiana % |
|---|
Wiadomości
Ze źródeł internetowych i od partnerskich agencji informacyjnych
Yahoo Finance
·
2 godziny temu
Branded Pharmaceuticals Stocks Q2 In Review: Zoetis (NYSE:ZTS) Vs Peers
Investing.com Canada
·
6 godzin temu
Zoetis appoints Iris Knobloch to board of directors By Investing.com
TipRanks
·
6 godzin temu
Zoetis Appoints Iris Knobloch to Board of Directors
Yahoo Finance
·
7 godzin temu
Zoetis Appoints Iris Knobloch to its Board of Directors
Profil
Zoetis Inc., headquartered in Parsippany, New Jersey, is the largest producer of medicine and vaccinations for pets and livestock worldwide. The company's products include antiparasitics, vaccines, products that relieve itch, anti-infectives, products that alleviate pain, animal health diagnostics, as well as hormones, cardiopulmonary, topical and oral hygiene therapeutics, central nervous system drugs, diuretics, antiemetic, euthanasia, and hepato-digestive products. The company has operations in over 50 countries.
In 2025, 70% of the company's revenue came from products for pets and 29% of the company's revenues came from products for livestock. In 2025, 54% of the company's revenue came from customers in the United States. Of this revenue, 79% came from products for dogs and cats, 13% came from products for cattle, and 4% came from products for horses. In 2025, 46% of the company's revenue came from international customers. Of this revenue, 53% came from products for dogs and cats, 19% came from products for cattle, 9% came from products for swine, 7% came from products for poultry, and 3% came from products for horses. Wikipedia